Skip to main content
. 2021 Dec 20;10(12):1560. doi: 10.3390/antibiotics10121560

Figure 2.

Figure 2

The cell viability of human PBMCs (A) and red blood cells (B) after treatment with (Fxr)3 at different concentrations. Data were obtained from three individual experiments. Stars indicate a significant difference compared with the negative control (p < 0.05).